Article Versions Notes

Katona G, Sabir F, Sipos B, Naveed M, Schelz Z, Zupkó I, Csóka I. Development of Lomustine and n-Propyl Gallate Co-Encapsulated Liposomes for Targeting Glioblastoma Multiforme via Intranasal Administration. Pharmaceutics. 2022; 14(3):631. https://doi.org/10.3390/pharmaceutics14030631

Katona, Gábor, Fakhara Sabir, Bence Sipos, Muhammad Naveed, Zsuzsanna Schelz, István Zupkó, and Ildikó Csóka. 2022. "Development of Lomustine and n-Propyl Gallate Co-Encapsulated Liposomes for Targeting Glioblastoma Multiforme via Intranasal Administration" Pharmaceutics 14, no. 3: 631. https://doi.org/10.3390/pharmaceutics14030631

Katona, G., Sabir, F., Sipos, B., Naveed, M., Schelz, Z., Zupkó, I., & Csóka, I. (2022). Development of Lomustine and n-Propyl Gallate Co-Encapsulated Liposomes for Targeting Glioblastoma Multiforme via Intranasal Administration. Pharmaceutics, 14(3), 631. https://doi.org/10.3390/pharmaceutics14030631